The 'true' prevalence of bipolar II disorder

Current Opinion in Psychiatry

Volumn 25, Issue 1, 2012, Pages 19-23

  Merikangas, Kathleen R ^a   Lamers, Femke ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

bipolar II disorder; epidemiology; hypomania

Indexed keywords

ANTIDEPRESSANT AGENT; LAMOTRIGINE; LITHIUM; PRAMIPEXOLE; QUETIAPINE;

BIPOLAR II DISORDER; BRAZIL; CANADA; COMORBIDITY; DRUG EFFICACY; FAMILY HISTORY; HUMAN; HYPOMANIA; MANIA; PREVALENCE; REVIEW; SUICIDE ATTEMPT; VERBAL MEMORY; VISUAL MEMORY;

BIPOLAR DISORDER; COGNITION DISORDERS; HUMANS; INCIDENCE; PREVALENCE;

EID: 83155180180     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0b013e32834de3de     Document Type: Review

References (31)

1. Craddock N, O'Donovan MC, Owen MJ. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull 2006; 32:9-16. (Pubitemid 43063811)
2. Angst J, Cui L, Swendsen J, et al. Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication. Am J Psychiatry 2010; 167:1194-1201.
3. Angst J, Gamma A. A new bipolar spectrum concept: a brief review. Bipolar Disord 2002; 4 (Suppl. 1):11-14.
4. Beesdo K, Hofler M, Leibenluft E, et al. Mood episodes and mood disorders: patterns of incidence and conversion in the first three decades of life. Bipolar Disord 2009; 11:637-649.
5. Lewinsohn PM, Seeley JR, Klein DN. Bipolar disorders during adolescence. Acta Psychiatr Scand Suppl 2003; 418:47-50.
6. Benazzi F, Akiskal HS. Delineating bipolar II mixed states in the Ravenna-San Diego collaborative study: the relative prevalence and diagnostic significance of hypomanic features during major depressive episodes. J Affect Disord 2001; 67:115-122. (Pubitemid 34187614)
7. Akiskal HS, Mallya G. Criteria for the 'soft' bipolar spectrum: treatment implications. Psychopharmacol Bull 1987; 23:68-73. (Pubitemid 17111666)
8. Angst J. The bipolar spectrum. Br J Psychiatry 2007; 190:189-191. (Pubitemid 46383999)
9. Klerman GL. The spectrum of mania. Compr Psychiatry 1981; 22:11-20. (Pubitemid 11129187)
10. Angst J, Gamma A, Neuenschwander M, et al. Prevalence of mental disorders in the Zurich Cohort Study: a twenty year prospective study. Epidemiol Psichiatr Soc 2005; 14:68-76. (Pubitemid 40910388)
11. Benazzi F, Akiskal HS. The modified SCID Hypomania Module (SCID-Hba): a detailed systematic phenomenologic probing. J Affect Disord 2009; 117:131-136.
12. Lewinsohn PM, Shankman SA, Gau JM, et al. The prevalence and co-morbidity of subthreshold psychiatric conditions. Psychol Med 2004; 34:613-622. (Pubitemid 38735456)
13. Merikangas KR, He JP, Burstein M, et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication - Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry 2010; 49:980-989.
14. Angst J, Gamma A, Bowden CL, et al. Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes. Eur Arch Psychiatry Clin Neurosci 2011. [Epub ahead of print].
15. Spence D. Bad medicine: bipolar II disorder. BMJ 2011; 342:d2767.
16. Angell M. The illusions of psychiatry. The New York review of books. 2011. http://www.nybooks.com/articles/archives/2011/jul/14/illusions-of- psychiatry/ [Accessed 21 September 2011]
17. Zimmermann P, Bruckl T, Nocon A, et al. Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Arch Gen Psychiatry 2009; 66:1341-1352.
18. McNamara RK, Nandagopal JJ, Strakowski SM, et al. Preventive strategies for early-onset bipolar disorder: towards a clinical staging model. CNS Drugs 2010; 24:983-996.
19. Hirschfeld RM, Cass AR, Holt DC, et al. Screening for bipolar disorder in patients treated for depression in a family medicine clinic. J Am Board Fam Pract 2005; 18:233-239. (Pubitemid 41663994)
20. Merikangas KR, Jin R, He JP, et al. Prevalence and correlates of bipolar spectrum disorder in the World Mental Health survey initiative. Arch Gen Psychiatry 2011; 68:241-251.
21. Bulloch AG, Currie S, Guyn L, et al. Estimates of the treated prevalence of bipolar disorders by mental health services in the general population: comparison of results from administrative and health survey data. Chronic Dis Inj Can 2011; 31:129-134.
22. Chou KL, Mackenzie CS, Liang K, et al. Three-year incidence and predictors of first-onset of DSM-IV mood, anxiety, and substance use disorders in older adults: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2011; 72:144-155.
23. Van Meter AR, Moreira AL, Youngstrom EA. Meta-analysis of epidemiologic studies of pediatric bipolar disorder. J Clin Psychiatry 2011; 72:1250-1256.
24. Tijssen MJ, van Os J, Wittchen HU, et al. Evidence that bipolar disorder is the poor outcome fraction of a common developmental phenotype: an 8-year cohort study in young people. Psychol Med 2010; 40:289-299.
25. Jansen K, Ores Lda C, Cardoso Tde A, et al. Prevalence of episodes of mania and hypomania and associated comorbidities among young adults. J Affect Disord 2011; 130:328-333.
26. Novick DM, Swartz HA, Frank E. Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence. Bipolar Disord 2010; 12:1-9.
27. Bora E, Yucel M, Pantelis C, et al. Meta-analytic review of neurocognition in bipolar II disorder. Acta Psychiatr Scand 2011; 123:165-174.
28. Sole B, Bonnin CM, Torrent C, et al. Neurocognitive impairment and psychosocial functioning in bipolar II disorder. Acta Psychiatr Scand 2011. [Epub ahead of print]
29. Alloy LB, Urosevic S, Abramson LY, et al. Progression along the bipolar spectrum: a longitudinal study of predictors of conversion from bipolar spectrum conditions to bipolar I and II disorders. J Abnorm Psychol 2011. [Epub ahead of print].
30. Tijssen MJ, Van Os J, Wittchen HU, et al. Risk factors predicting onset and persistence of subthreshold expression of bipolar psychopathology among youth from the community. Acta Psychiatr Scand 2010; 122:255-266.
31. Swartz HA, Thase ME. Pharmacotherapy for the treatment of acute bipolar II depression: current evidence. J Clin Psychiatry 2011; 72:356-366.